Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

Neurocrine Bio. (NBIX) PT Raised to $200 at Canaccord

April 6, 2026 2:41 PM EDT

Canaccord analyst Sumant Kulkarni raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $200.00 (from $164.00) while maintaining a Buy rating.

... More